NPPB and Miyoshi myopathy: Milani et al. demonstrated the relationship between NT-proBNP levels and patient frailty, delineated by age, Eastern Cooperative Oncology Group performance status (ECOG-PS), ADL, and CCI, further showing the prognostic implications of NT-proBNP in patients with MM using a cohort from Mayo Clinic [14].